{
  "id": 12443796,
  "title": "Why is Twist Bioscience stock plunging today?",
  "url": "https://urgent.news/2026/10/06/why-is-twist-bioscience-stock-plunging-today",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-06T18:36:54.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/stock-market-news/why-is-twist-bioscience-stock-plunging-today-93CH-4935087"
  },
  "original_language": "en",
  "account": "Twist Bioscience's stock experienced a significant drop of 16.1% in trading, reaching $171.96 after briefly touching a 52-week high of $219.71. This decline followed the news of ARK Invest's ongoing sale of the synthetic biology company for 21 consecutive days, totaling $18 million worth of shares. The reduction in buying pressure was further exacerbated by insider sales, including those from the Chief Operating Officer, Director, and CEO. Despite a moderate buy consensus rating from analysts and substantial year-to-date gains of 495%, the stock's valuation was deemed overvalued by 42.9%. The broader market remained unaffected as major indices like the S&P 500, Dow Jones, and Nasdaq continued to climb. The combination of ARK's persistent selling, insider disposals, and the stock's valuation concerns led to a significant mean-reversion selloff in Twist Bioscience.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}